Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)

Condition:   Anaemia Interventions:   Drug: Daprodustat tablets;   Drug: Matching placebo tablets;   Drug: Epoetin alfa vials;   Drug: Saline vials or bags Sponsor:   GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials